TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
LTRN

Lantern Pharma Inc

Healthcare · Biotechnology

1.40$ +2.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LTRN
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +218.5% +1,321.2% +263.2% -20.4% -25.8% -41.4% -56.8%
– +176.9% +1,541.5% +259.3% -19.2% -26.2% -41.7% -57.2%
– +176.8% +1,460.8% +167.9% -27.8% -41.0% -65.8% -41.1%
– +176.8% +1,460.8% +267.8% -22.0% -25.2% -41.9% -57.9%
– – – – +227.1% +45.3% -88.7% -69.1%
– – – – – – – –
– +87.6% +145.6% +905.2% -77.8% – – –
– -24.9% +35.1% +260.0% +17.6% -2.1% +60.0% +2.7%
– -24.9% +12.9% +321.1% +20.3% -4.3% +61.7% +3.9%
– – – – -65.2% +227.0% +10.3% +41,060.0%
– +389.9% -9.6% +402.9% -57.1% +1.1% +339.4% +6.8%
– – – – – – – –
– – +1,988.3% +263.3% -21.7% -27.0% -48.2% -69.2%
– – – – – – – –
– +0.8% -0.7% +75.3% -0.5% -0.1% -0.7% +1.3%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?